CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronavirusesKatie E. Lineburg, Stéphanie Gras, Christian A. Lobos et al.|Immunity|2021Cited by 206
The role of T‐cell immunity in COVID‐19 severity amongst people living with type II diabetesZhen Tong, Kirsty R. Short, Emma J. Grant et al.|FEBS Journal|2021Cited by 22
Elevated BMI reduces the humoral response to SARS‐CoV‐2 infectionZhen Tong, Kirsty R. Short, Julian D. J. Sng et al.|Clinical & Translational Immunology|2023Cited by 17
In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprintingWen Juan Tu, Sudha Rao, Michelle Melino et al.|Nature Communications|2023Cited by 16
COVID-19 vaccine booster induces a strong CD8 <sup>+</sup> T cell response against Omicron variant epitopes in HLA-A*02:01 <sup>+</sup> individualsAndrea Nguyen, Stéphanie Gras, Christopher Szeto et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 4